{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:45:03Z","timestamp":1790775903360,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10072-021-05601-8","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T03:26:15Z","timestamp":1631849175000},"page":"4927-4936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["\u201cParkinson\u2019s disease\u201d on the way to progressive supranuclear palsy: a review on PSP-parkinsonism"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4626-9588","authenticated-orcid":false,"given":"J\u00e1n","family":"Necp\u00e1l","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Borsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibi\u00e1na","family":"Jele\u0148ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"5601_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","volume":"10","author":"JC Steele","year":"1964","unstructured":"Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10:333\u2013359. https:\/\/doi.org\/10.1001\/archneur.1964.00460160003001","journal-title":"Arch Neurol"},{"key":"5601_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","volume":"14","author":"J G\u00f6tz","year":"2019","unstructured":"G\u00f6tz J, Halliday G, Nisbet RM (2019) Molecular pathogenesis of the tauopathies. Annu Rev Pathol 14:239\u2013261. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012936","journal-title":"Annu Rev Pathol"},{"key":"5601_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.14802\/jmd.15060","volume":"9","author":"H Ling","year":"2016","unstructured":"Ling H (2016) Clinical Approach to Progressive Supranuclear Palsy. J Mov Disord 9:3\u201313. https:\/\/doi.org\/10.14802\/jmd.15060","journal-title":"J Mov Disord"},{"key":"5601_CR4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/jnnp-2013-305740","volume":"85","author":"C Colosimo","year":"2014","unstructured":"Colosimo C, Bak TH, Bologna M, Berardelli A (2014) Fifty years of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 85:938\u2013944. https:\/\/doi.org\/10.1136\/jnnp-2013-305740","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5601_CR5","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","volume":"29","author":"Respondek G, Stamelou M, Kurz C, Ferguson LW, Rajput A, Chiu WZ, van Swieten JC, Troakes C, Al Sarraj S, Gelpi E, Gaig C, Tolosa E, Oertel WH, Giese A, Roeber S, Arzberger T, Wagenpfeil S, H\u00f6glinger GU, Movement Disorder Society-endorsed PSP Study Group","year":"2014","unstructured":"Respondek G, Stamelou M, Kurz C, Ferguson LW, Rajput A, Chiu WZ, van Swieten JC, Troakes C, Al Sarraj S, Gelpi E, Gaig C, Tolosa E, Oertel WH, Giese A, Roeber S, Arzberger T, Wagenpfeil S, H\u00f6glinger GU, Movement Disorder Society-endorsed PSP Study Group (2014) The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord 29:1758\u20131766. https:\/\/doi.org\/10.1002\/mds.26054","journal-title":"Mov Disord"},{"key":"5601_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/07317115.2019.1694115","volume":"43","author":"TP Parthimos","year":"2020","unstructured":"Parthimos TP, Schulpis KH (2020) The progressive supranuclear palsy: past and present aspects. Clin Gerontol 43:155\u2013180. https:\/\/doi.org\/10.1080\/07317115.2019.1694115","journal-title":"Clin Gerontol"},{"key":"5601_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/ane.12546","volume":"134","author":"G Lopez","year":"2016","unstructured":"Lopez G, Bayulkem K, Hallett M (2016) Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants. Acta Neurol Scand 134:242\u2013249. https:\/\/doi.org\/10.1111\/ane.12546","journal-title":"Acta Neurol Scand"},{"key":"5601_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fneur.2020.00180","volume":"11","author":"P Alster","year":"2020","unstructured":"Alster P, Madetko N, Koziorowski D, Friedman A (2020) Progressive supranuclear palsy-parkinsonism predominant (PSP-P)-a clinical challenge at the boundaries of PSP and Parkinson\u2019s disease (PD). Front Neurol 11:180. https:\/\/doi.org\/10.3389\/fneur.2020.00180","journal-title":"Front Neurol"},{"key":"5601_CR9","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","volume":"128","author":"DR Williams","year":"2005","unstructured":"Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson\u2019s syndrome and PSP-parkinsonism. Brain 128:1247\u20131258. https:\/\/doi.org\/10.1093\/brain\/awh488","journal-title":"Brain"},{"key":"5601_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/mds.22977","volume":"25","author":"DR Williams","year":"2010","unstructured":"Williams DR, Lees AJ (2010) What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)? Mov Disord 25:357\u2013362. https:\/\/doi.org\/10.1002\/mds.22977","journal-title":"Mov Disord"},{"key":"5601_CR11","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/mds.21698","volume":"22","author":"DR Williams","year":"2007","unstructured":"Williams DR, Holton JL, Strand K, Revesz T, Lees AJ (2007) Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 22:2235\u20132241. https:\/\/doi.org\/10.1002\/mds.21698","journal-title":"Mov Disord"},{"key":"5601_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/nan.12037","volume":"40","author":"H Ling","year":"2014","unstructured":"Ling H, de Silva R, Massey LA, Courtney R, Hondhamuni G, Bajaj N, Lowe J, Holton JL, Lees A, Revesz T (2014) Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. Neuropathol Appl Neurobiol 40:149\u2013163. https:\/\/doi.org\/10.1111\/nan.12037","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5601_CR13","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/13554794.2011.627345","volume":"18","author":"A Hassan","year":"2012","unstructured":"Hassan A, Parisi JE, Josephs KA (2012) Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. Neurocase 18:478\u2013488. https:\/\/doi.org\/10.1080\/13554794.2011.627345","journal-title":"Neurocase"},{"key":"5601_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/mds.22946","volume":"25","author":"JD Rohrer","year":"2010","unstructured":"Rohrer JD, Paviour D, Bronstein AM, O\u2019Sullivan SS, Lees A, Warren JD (2010) Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis. Mov Disord 25:179\u2013188. https:\/\/doi.org\/10.1002\/mds.22946","journal-title":"Mov Disord"},{"key":"5601_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/mdc3.12796","volume":"6","author":"JL Whitwell","year":"2019","unstructured":"Whitwell JL, Stevens CA, Duffy JR, Clark HM, Machulda MM, Strand EA, Martin PR, Utianski RL, Botha H, Spychalla AJ, Senjem ML, Schwarz CG, Jack CR Jr, Ali F, Hassan A, Josephs KA (2019) An evaluation of the progressive supranuclear palsy speech\/language variant. Mov Disord 6:452\u2013461. https:\/\/doi.org\/10.1002\/mdc3.12796","journal-title":"Mov Disord"},{"key":"5601_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s40478-016-0391-7","volume":"4","author":"C Kurz","year":"2016","unstructured":"Kurz C, Ebersbach G, Respondek G, Giese A, Arzberger T, H\u00f6glinger GU (2016) An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability. Acta Neuropathol Commun 4:120. https:\/\/doi.org\/10.1186\/s40478-016-0391-7","journal-title":"Acta Neuropathol Commun"},{"key":"5601_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14802\/jmd.16059","volume":"10","author":"Z Xu","year":"2017","unstructured":"Xu Z, Lim T, Au WL, Tan L (2017) Progressive supranuclear gaze palsy with predominant cerebellar ataxia: a case series with videos. J Mov Disord 10:87\u201391. https:\/\/doi.org\/10.14802\/jmd.16059","journal-title":"J Mov Disord"},{"key":"5601_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jns.2012.09.005","volume":"323","author":"S Nagao","year":"2012","unstructured":"Nagao S, Yokota O, Nanba R, Takata H, Haraguchi T, Ishizu H, Ikeda C, Takeda N, Oshima E, Sakane K, Terada S, Ihara Y, Uchitomi Y (2012) Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia. J Neurol Sci 323:147\u2013153. https:\/\/doi.org\/10.1016\/j.jns.2012.09.005","journal-title":"J Neurol Sci"},{"key":"5601_CR19","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/brain\/awm301","volume":"131","author":"Z Ahmed","year":"2008","unstructured":"Ahmed Z, Josephs KA, Gonzalez J, DelleDonne A, Dickson DW (2008) Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. Brain 131:460\u2013472. https:\/\/doi.org\/10.1093\/brain\/awm301","journal-title":"Brain"},{"key":"5601_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117293","volume":"421","author":"JC Morgan","year":"2021","unstructured":"Morgan JC, Ye X, Mellor JA, Golden KJ, Zamudio J, Chiodo LA, Bao Y, Xie T (2021) Disease course and treatment patterns in progressive supranuclear palsy: a real-world study. J Neurol Sci 421:117293. https:\/\/doi.org\/10.1016\/j.jns.2020.117293","journal-title":"J Neurol Sci"},{"key":"5601_CR21","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00702-010-0563-8","volume":"118","author":"K Srulijes","year":"2011","unstructured":"Srulijes K, Mallien G, Bauer S, Dietzel E, Gr\u00f6ger A, Ebersbach G, Berg D, Maetzler W (2011) In vivo comparison of Richardson\u2019s syndrome and progressive supranuclear palsy-parkinsonism. J Neural Transm (Vienna) 118:1191\u20131197. https:\/\/doi.org\/10.1007\/s00702-010-0563-8","journal-title":"J Neural Transm (Vienna)"},{"key":"5601_CR22","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","volume":"16","author":"AL Boxer","year":"2017","unstructured":"Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, H\u00f6glinger GU (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16:552\u2013563. https:\/\/doi.org\/10.1016\/S1474-4422(17)30157-6","journal-title":"Lancet Neurol"},{"key":"5601_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.parkreldis.2019.07.010","volume":"66","author":"A Shoeibi","year":"2019","unstructured":"Shoeibi A, Litvan I, Tolosa E, Ser TD, Lee E, Investigators TAUROS (2019) Progression of two progressive supranuclear palsy phenotypes with comparable initial disability. Parkinsonism Relat Disord 66:87\u201393. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.07.010","journal-title":"Parkinsonism Relat Disord"},{"key":"5601_CR24","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00415-014-7384-x","volume":"261","author":"M Jecmenica-Lukic","year":"2014","unstructured":"Jecmenica-Lukic M, Petrovic IN, Pekmezovic T, Kostic VS (2014) Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study. J Neurol 261:1575\u20131583. https:\/\/doi.org\/10.1007\/s00415-014-7384-x","journal-title":"J Neurol"},{"key":"5601_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2017.10.002","volume":"45","author":"C Pellicano","year":"2017","unstructured":"Pellicano C, Assogna F, Cellupica N, Piras F, Pierantozzi M, Stefani A, Cerroni R, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G (2017) Neuropsychiatric and cognitive profile of early Richardson\u2019s syndrome, progressive supranuclear palsy-parkinsonism and Parkinson\u2019s disease. Parkinsonism Relat Disorders 45:50\u201356. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.10.002","journal-title":"Parkinsonism Relat Disorders"},{"key":"5601_CR26","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/mdc3.12314","volume":"3","author":"W Maetzler","year":"2016","unstructured":"Maetzler W, Rattay TW, Hobert MA, Synofzik M, Bader A, Berg D, Schaeffer E, Rommel N, Devos D, Bloem BR, Bender B (2016) Freezing of swallowing. Mov Disord Clin Pract 3:490\u2013493. https:\/\/doi.org\/10.1002\/mdc3.12314","journal-title":"Mov Disord Clin Pract"},{"key":"5601_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/jnnp.57.1.79","volume":"57","author":"TW Robbins","year":"1994","unstructured":"Robbins TW, James M, Owen AM, Lange KW, Lees AJ, Leigh PN, Marsden CD, Quinn NP, Summers BA (1994) Cognitive deficits in progressive supranuclear palsy, Parkinson\u2019s disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 57:79\u201388. https:\/\/doi.org\/10.1136\/jnnp.57.1.79","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5601_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.14802\/jmd.19066","volume":"13","author":"SP Chaithra","year":"2020","unstructured":"Chaithra SP, Prasad S, Holla VV, Stezin A, Kamble N, Yadav R, Pal PK (2020) The non-motor symptom profile of progressive supranuclear palsy. J Mov Disord 13:118\u2013126. https:\/\/doi.org\/10.14802\/jmd.19066","journal-title":"J Mov Disord"},{"key":"5601_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.parkreldis.2020.03.003","volume":"74","author":"C Painous","year":"2020","unstructured":"Painous C, Mart\u00ed MJ, Simonet C, Garrido A, Valldeoriola F, Mu\u00f1oz E, C\u00e1mara A, Compta Y (2020) Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: the step-back PSP study. Parkinsonism Relat Disord 74:67\u201373. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.03.003","journal-title":"Parkinsonism Relat Disord"},{"key":"5601_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.14802\/jmd.17067","volume":"11","author":"YC Lee","year":"2018","unstructured":"Lee YC, Williams DR, Anderson J (2018) Prospective characterization of cognitive function in typical and \u2018brainstem predominant\u2019 progressive supranuclear palsy phenotypes. J Mov Disord 11:72\u201377. https:\/\/doi.org\/10.14802\/jmd.17067","journal-title":"J Mov Disord"},{"key":"5601_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/jnp.12232.10.1111\/jnp.12232","author":"MG Vaccaro","year":"2020","unstructured":"Vaccaro MG, Sarica A, Quattrone A, Chiriaco C, Salsone M, Morelli M, Quattrone A (2020) Neuropsychological assessment could distinguish among different clinical phenotypes of progressive supranuclear palsy: A Machine Learning approach. J Neuropsych. https:\/\/doi.org\/10.1111\/jnp.12232.10.1111\/jnp.12232","journal-title":"J Neuropsych"},{"key":"5601_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/wnl.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1\u20139. https:\/\/doi.org\/10.1212\/wnl.47.1.1","journal-title":"Neurology"},{"key":"5601_CR33","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, M\u00fcller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord"},{"key":"5601_CR34","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/mds.27619","volume":"34","author":"F Ali","year":"2019","unstructured":"Ali F, Martin PR, Botha H, Ahlskog JE, Bower JH, Masumoto JY, Maraganore D, Hassan A, Eggers S, Boeve BF, Knopman DS, Drubach D, Petersen RC, Dunkley ED, van Gerpen J, Uitti R, Whitwell JL, Dickson DW, Josephs KA (2019) Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy. Mov Disorders 34:1144\u20131153. https:\/\/doi.org\/10.1002\/mds.27619","journal-title":"Mov Disorders"},{"key":"5601_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12208","volume":"41","author":"GG Kovacs","year":"2015","unstructured":"Kovacs GG (2015) Invited review: Neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol 41:3\u201323. https:\/\/doi.org\/10.1111\/nan.12208","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5601_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-3-7091-6641-3_11","volume":"42","author":"PL Lantos","year":"1994","unstructured":"Lantos PL (1994) The neuropathology of progressive supranuclear palsy. J Neural Transm Suppl 42:137\u2013152. https:\/\/doi.org\/10.1007\/978-3-7091-6641-3_11","journal-title":"J Neural Transm Suppl"},{"key":"5601_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/01.wnl.0000286938.39473.0e","volume":"70","author":"DR Williams","year":"2008","unstructured":"Williams DR, Lees AJ, Wherrett JR, Steele JC (2008) J. Clifford Richardson and 50 years of progressive supranuclear palsy. Neurology 70:566\u2013573. https:\/\/doi.org\/10.1212\/01.wnl.0000286938.39473.0e","journal-title":"Neurology"},{"key":"5601_CR38","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","volume":"23","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA (2010) Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 23:394\u2013400. https:\/\/doi.org\/10.1097\/WCO.0b013e32833be924","journal-title":"Curr Opin Neurol"},{"key":"5601_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB, Coughlin D, Giese A, Grossman M, Kurz C, McMillan CT, Gelpi E, Compta Y, van Swieten JC, Laat LD, Troakes C, Al-Sarraj S, Robinson JL, Roeber S, Xie SX, H\u00f6glinger GU (2020) Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol 140:99\u2013119. https:\/\/doi.org\/10.1007\/s00401-020-02158-2","journal-title":"Acta Neuropathol"},{"key":"5601_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00234-017-1812-4","volume":"59","author":"K Sakurai","year":"2017","unstructured":"Sakurai K, Tokumaru AM, Shimoji K, Murayama S, Kanemaru K, Morimoto S, Aiba I, Nakagawa M, Ozawa Y, Shimohira M, Matsukawa N, Hashizume Y, Shibamoto Y (2017) Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. Neuroradiology 59:431\u2013443. https:\/\/doi.org\/10.1007\/s00234-017-1812-4","journal-title":"Neuroradiology"},{"key":"5601_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1600-0404.2006.00767.x","volume":"116","author":"M Cosottini","year":"2007","unstructured":"Cosottini M, Ceravolo R, Faggioni L, Lazzarotti G, Michelassi MC, Bonuccelli U, Murri L, Bartolozzi C (2007) Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand 116:37\u201342. https:\/\/doi.org\/10.1111\/j.1600-0404.2006.00767.x","journal-title":"Acta Neurol Scand"},{"key":"5601_CR42","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1212\/01.wnl.0000203342.77115.bf","volume":"66","author":"K Gr\u00f6schel","year":"2006","unstructured":"Gr\u00f6schel K, Kastrup A, Litvan I, Schulz JB (2006) Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology 66:949\u2013950. https:\/\/doi.org\/10.1212\/01.wnl.0000203342.77115.bf","journal-title":"Neurology"},{"key":"5601_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/jnnp-2019-321354","volume":"91","author":"M Picillo","year":"2020","unstructured":"Picillo M, Tepedino MF, Abate F, Erro R, Ponticorvo S, Tartaglione S, Volpe G, Frosini D, Cecchi P, Cosottini M, Ceravolo R, Esposito F, Pellecchia MT, Barone P, Manara R (2020) Midbrain MRI assessments in progressive supranuclear palsy subtypes. J Neurol Neurosurg Psychiatry 91:98\u2013103. https:\/\/doi.org\/10.1136\/jnnp-2019-321354","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5601_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/mds.23293","volume":"26","author":"G Longoni","year":"2011","unstructured":"Longoni G, Agosta F, Kosti\u0107 VS, Stojkovi\u0107 T, Pagani E, Sto\u0161i\u0107-Opin\u0107al T, Filippi M (2011) MRI measurements of brainstem structures in patients with Richardson\u2019s syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson\u2019s disease. Mov Disord 26:247\u2013255. https:\/\/doi.org\/10.1002\/mds.23293","journal-title":"Mov Disord"},{"key":"5601_CR45","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/mds.27621","volume":"34","author":"A Quattrone","year":"2019","unstructured":"Quattrone A, Morelli M, Vescio B, Nigro S, Le Piane E, Sabatini U, Caracciolo M, Vescio V, Quattrone A, Barbagallo G, Stan\u00e0 C, Nicoletti G, Arabia G, Nistic\u00f2 R, Novellino F, Salsone M (2019) Refining initial diagnosis of Parkinson\u2019s disease after follow-up: a 4-year prospective clinical and magnetic resonance imaging study. Mov Disord 34:487\u2013495. https:\/\/doi.org\/10.1002\/mds.27621","journal-title":"Mov Disord"},{"key":"5601_CR46","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/mdc3.12473","volume":"4","author":"A Lenka","year":"2017","unstructured":"Lenka A, Pasha SA, Mangalore S, George L, Jhunjhunwala KR, Bagepally BS, Naduthota RM, Saini J, Yadav R, Pal PK (2017) Role of corpus callosum volumetry in differentiating the subtypes of progressive supranuclear palsy and early Parkinson\u2019s disease. Mov Disord Clin Pract 4:552\u2013558. https:\/\/doi.org\/10.1002\/mdc3.12473","journal-title":"Mov Disord Clin Pract"},{"key":"5601_CR47","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3174\/ajnr.A5048","volume":"38","author":"G Nicoletti","year":"2017","unstructured":"Nicoletti G, Caligiuri ME, Cherubini A, Morelli M, Novellino F, Arabia G, Salsone M, Quattrone A (2017) A fully automated, atlas-based approach for superior cerebellar peduncle evaluation in progressive supranuclear palsy phenotypes. Am J Neuroradiol 38:523\u2013530. https:\/\/doi.org\/10.3174\/ajnr.A5048","journal-title":"Am J Neuroradiol"},{"key":"5601_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2020.02.007","volume":"72","author":"T Potrusil","year":"2020","unstructured":"Potrusil T, Krismer F, Beliveau V, Seppi K, M\u00fcller C, Troger F, G\u00f6bel G, Steiger R, Gizewski ER, Poewe W, Scherfler C (2020) Diagnostic potential of automated tractography in progressive supranuclear palsy variants. Parkinsonism Relat Disord 72:65\u201371. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.02.007","journal-title":"Parkinsonism Relat Disord"},{"key":"5601_CR49","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1474-4422(08)70239-4","volume":"7","author":"D Berg","year":"2008","unstructured":"Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7:1044\u20131055. https:\/\/doi.org\/10.1016\/S1474-4422(08)70239-4","journal-title":"Lancet Neurol"},{"key":"5601_CR50","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/mds.22981","volume":"25","author":"J Ebentheuer","year":"2010","unstructured":"Ebentheuer J, Canelo M, Trautmann E, Trenkwalder C (2010) Substantia nigra echogenicity in progressive supranuclear palsy. Mov Disord 25:773\u2013777. https:\/\/doi.org\/10.1002\/mds.22981","journal-title":"Mov Disord"},{"key":"5601_CR51","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/ene.12034","volume":"20","author":"VS Kosti\u0107","year":"2013","unstructured":"Kosti\u0107 VS, Mijajlovi\u0107 M, Smajlovi\u0107 D, Luki\u0107 MJ, Tomi\u0107 A, Svetel M (2013) Transcranial brain sonography findings in two main variants of progressive supranuclear palsy. Eur J Neurol 20:552\u2013557. https:\/\/doi.org\/10.1111\/ene.12034","journal-title":"Eur J Neurol"},{"key":"5601_CR52","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.parkreldis.2013.04.010","volume":"19","author":"I Sastre-Bataller","year":"2013","unstructured":"Sastre-Bataller I, V\u00e1zquez JF, Mart\u00ednez-Torres I, Sahuquillo P, Rubio-Agust\u00ed I, Burguera JA, Ferrer JM, Valero C, Tembl JI (2013) Mesencephalic area measured by transcranial sonography in the differential diagnosis of parkinsonism. Park Relat Disord 19:732\u2013736. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.04.010","journal-title":"Park Relat Disord"},{"key":"5601_CR53","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/mds.27038","volume":"32","author":"Whitwell JL, H\u00f6glinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, van Eimeren T, Golbe, Kassubek J, Kurz C, Litvan I, Pantelyat A, Rabinovici G, Respondek G, Rominger A, Rowe JB, Stamelou M, Josephs KA, Movement Disorder Society-endorsed PSP Study Group","year":"2017","unstructured":"Whitwell JL, H\u00f6glinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, van Eimeren T, Golbe, Kassubek J, Kurz C, Litvan I, Pantelyat A, Rabinovici G, Respondek G, Rominger A, Rowe JB, Stamelou M, Josephs KA, Movement Disorder Society-endorsed PSP Study Group (2017) Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? Mov Disord 32:955\u2013971. https:\/\/doi.org\/10.1002\/mds.27038","journal-title":"Mov Disord"},{"key":"5601_CR54","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1097\/MNM.0b013e32833e5f90","volume":"31","author":"WY Lin","year":"2010","unstructured":"Lin WY, Lin KJ, Weng YH, Yen TC, Shen LH, Liao MH, Lu CS (2010) Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy. Nucl Med Commun 31:974\u2013980. https:\/\/doi.org\/10.1097\/MNM.0b013e32833e5f90","journal-title":"Nucl Med Commun"},{"key":"5601_CR55","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jocn.2020.06.008","volume":"80","author":"P Zhao","year":"2020","unstructured":"Zhao P, Zhang B, Gao S, Li X (2020) Clinical, MRI and 18F-FDG-PET\/CT analysis of progressive supranuclear palsy. J Clin Neurosci 80:318\u2013323. https:\/\/doi.org\/10.1016\/j.jocn.2020.06.008","journal-title":"J Clin Neurosci"},{"key":"5601_CR56","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s00415-014-7256-4","volume":"261","author":"N Zalewski","year":"2014","unstructured":"Zalewski N, Botha H, Whitwell JL, Lowe V, Dickson DW, Josephs KA (2014) FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants. J Neurol 261:710\u2013716. https:\/\/doi.org\/10.1007\/s00415-014-7256-4","journal-title":"J Neurol"},{"key":"5601_CR57","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/mds.28217","volume":"35","author":"G Mart\u00ed-Andr\u00e9s","year":"2020","unstructured":"Mart\u00ed-Andr\u00e9s G, van Bommel L, Meles SK, Riverol M, Valent\u00ed R, Kogan RV, Renken RJ, Gurvits V, van Laar T, Pagani M, Prieto E, Luquin MR, Leenders KL, Arbizu J (2020) Multicenter validation of metabolic abnormalities related to PSP according to the MDS-PSP criteria. Mov Disord 35:2009\u20132018. https:\/\/doi.org\/10.1002\/mds.28217","journal-title":"Mov Disord"},{"key":"5601_CR58","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/mds.23975","volume":"27","author":"K Srulijes","year":"2012","unstructured":"Srulijes K, Reimold M, Liscic RM, Bauer S, Dietzel E, Liepelt-Scarfone I, Berg D, Maetzler W (2012) Fluorodeoxyglucose positron emission tomography in Richardson\u2019s syndrome and progressive supranuclear palsy-parkinsonism. Mov Disord 27:151\u2013155. https:\/\/doi.org\/10.1002\/mds.23975","journal-title":"Mov Disord"},{"key":"5601_CR59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fneur.2019.00101","volume":"10","author":"P Alster","year":"2019","unstructured":"Alster P, Madetko NK, Koziorowski DM, Kr\u00f3licki L, Budrewicz S, Friedman A (2019) Accumulation of tau protein, metabolism and perfusion-application and efficacy of positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging in the examination of progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS). Front Neurol 10:101. https:\/\/doi.org\/10.3389\/fneur.2019.00101","journal-title":"Front Neurol"},{"key":"5601_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.102152","volume":"25","author":"JL Whitwell","year":"2020","unstructured":"Whitwell JL, Tosakulwong N, Botha H, Ali F, Clark HM, Duffy JR, Utianski RL, Stevens CA, Weigand SD, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Ahlskog JE, Dickson DW, Josephs KA (2020) Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants. NeuroImage Clin 25:102152. https:\/\/doi.org\/10.1016\/j.nicl.2019.102152","journal-title":"NeuroImage Clin"},{"key":"5601_CR61","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3233\/JPD-202302","volume":"11","author":"Y Wen","year":"2021","unstructured":"Wen Y, Zhou Y, Jiao B, Shen L (2021) Genetics of progressive supranuclear palsy: a review. J Parkinsons Dis 11:93\u2013105. https:\/\/doi.org\/10.3233\/JPD-202302","journal-title":"J Parkinsons Dis"},{"key":"5601_CR62","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/ana.20449","volume":"57","author":"R Ros","year":"2005","unstructured":"Ros R, G\u00f3mez Garre P, Hirano M, Tai YF, Ampuero I, Vidal L, Rojo A, Fontan A, Vazquez A, Fanjul S, Hernandez J, Cantarero S, Hoenicka J, Jones A, Ahsan RL, Pavese N, Piccini P, Brooks DJ, Perez-Tur J, Nyggard T et al (2005) Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1. Ann Neurol 57:634\u2013641. https:\/\/doi.org\/10.1002\/ana.20449","journal-title":"Ann Neurol"},{"key":"5601_CR63","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/brain\/122.7.1233","volume":"122","author":"A Rojo","year":"1999","unstructured":"Rojo A, Pernaute RS, Font\u00e1n A, Ru\u00edz PG, Honnorat J, Lynch T, Chin S, Gonzalo I, R\u00e1bano A, Mart\u00ednez A, Daniel S, Pramstaller P, Morris H, Wood N, Lees A, Tabernero C, Nyggard T, Jackson AC, Hanson A, de Y\u00e9benes JG (1999) Clinical genetics of familial progressive supranuclear palsy. Brain 122:1233\u20131245. https:\/\/doi.org\/10.1093\/brain\/122.7.1233","journal-title":"Brain"},{"key":"5601_CR64","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/mds.26815","volume":"32","author":"M Sanchez-Contreras","year":"2017","unstructured":"Sanchez-Contreras M, Heckman MG, Tacik P, Diehl N, Brown PH, Soto-Ortolaza AI, Christopher EA, Walton RL, Ross OA, Golbe LI, Graff-Radford N, Wszolek ZK, Dickson DW, Rademakers R (2017) Study of LRRK2 variation in tauopathy: progressive supranuclear palsy and corticobasal degeneration. Mov Disord 32:115\u2013123. https:\/\/doi.org\/10.1002\/mds.26815","journal-title":"Mov Disord"},{"key":"5601_CR65","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1212\/01.wnl.0000239829.33936.73","volume":"67","author":"C Spanaki","year":"2006","unstructured":"Spanaki C, Latsoudis H, Plaitakis A (2006) LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP. Neurology 67:1518\u20131519. https:\/\/doi.org\/10.1212\/01.wnl.0000239829.33936.73","journal-title":"Neurology"},{"key":"5601_CR66","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ng.859","volume":"43","author":"GU H\u00f6glinger","year":"2011","unstructured":"H\u00f6glinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E et al (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43:699\u2013705. https:\/\/doi.org\/10.1038\/ng.859","journal-title":"Nat Genet"},{"key":"5601_CR67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-018-0267-3","volume":"13","author":"MY Sanchez-Contreras","year":"2018","unstructured":"Sanchez-Contreras MY, Kour N, Cook CN, Serie DJ, Heckman MG, Finch NA, Caselli RJ, Uitti RJ, Wszolek ZK, Graff-Radford N, Petrucelli L, Wang LS, Schellenberg GD, Dickson DW, Rademakers R, Ross OA (2018) Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci. Mol Neurodegener 13:37. https:\/\/doi.org\/10.1186\/s13024-018-0267-3","journal-title":"Mol Neurodegener"},{"key":"5601_CR68","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-018-1923-y","volume":"137","author":"K Men\u0161\u00edkov\u00e1","year":"2019","unstructured":"Men\u0161\u00edkov\u00e1 K, Tu\u010dkov\u00e1 L, Kola\u0159ikov\u00e1 K, Barton\u00edkov\u00e1 T, Vodi\u010dka R, Ehrmann J, Vrt\u011bl R, Proch\u00e1zka M, Ka\u0148ovsk\u00fd P, Kovacs GG (2019) Atypical parkinsonism of progressive supranuclear palsy-parkinsonism (PSP-P) phenotype with rare variants in FBXO7 and VPS35 genes associated with Lewy body pathology. Acta Neuropathol 137:171\u2013173. https:\/\/doi.org\/10.1007\/s00401-018-1923-y","journal-title":"Acta Neuropathol"},{"key":"5601_CR69","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/jnnp-2017-315857","volume":"88","author":"E Jabbari","year":"2017","unstructured":"Jabbari E, Zetterberg H, Morris HR (2017) Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers. J Neurol Neurosurg Neuropsychiatry 88:883\u2013888. https:\/\/doi.org\/10.1136\/jnnp-2017-315857","journal-title":"J Neurol Neurosurg Neuropsychiatry"},{"key":"5601_CR70","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/ane.13116","volume":"140","author":"R Constantinescu","year":"2019","unstructured":"Constantinescu R, Rosengren L, Eriksson B, Blennow K, Axelsson M (2019) Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism. Acta Neurol Scand 140:147\u2013156. https:\/\/doi.org\/10.1111\/ane.13116","journal-title":"Acta Neurol Scand"},{"key":"5601_CR71","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2020.04.014","volume":"73","author":"DG Coughlin","year":"2020","unstructured":"Coughlin DG, Litvan I (2020) Progressive supranuclear palsy: advances in diagnosis and management. Parkinsonism Relat Disord 73:105\u2013116. https:\/\/doi.org\/10.1016\/j.parkreldis.2020.04.014","journal-title":"Parkinsonism Relat Disord"},{"key":"5601_CR72","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1471-4159.2012.07911.x","volume":"123","author":"C Luk","year":"2012","unstructured":"Luk C, Compta Y, Magdalinou N, Mart\u00ed MJ, Hondhamuni G, Zetterberg H, Blennow K, Constantinescu R, Pijnenburg Y, Mollenhauer B, Trenkwalder C, Van Swieten J, Chiu WZ, Borroni B, C\u00e1mara A, Cheshire P, Williams DR, Lees AJ, de Silva R (2012) Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies. J Neurochem 123:396\u2013405. https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07911.x","journal-title":"J Neurochem"},{"key":"5601_CR73","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1002\/mds.21578","volume":"22","author":"R Constantinescu","year":"2007","unstructured":"Constantinescu R, Richard I, Kurlan R (2007) Levodopa responsiveness in disorders with parkinsonism: a review of the literature. Mov Disord 22:2141\u20132295. https:\/\/doi.org\/10.1002\/mds.21578","journal-title":"Mov Disord"},{"key":"5601_CR74","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/00002826-199308000-00006","volume":"16","author":"KA Nieforth","year":"1993","unstructured":"Nieforth KA, Golbe LI (1993) Retrospective study of drug response in 87 patients with progressive supranuclear palsy. Clin Neuropharmacol 16:338\u2013346. https:\/\/doi.org\/10.1097\/00002826-199308000-00006","journal-title":"Clin Neuropharmacol"},{"key":"5601_CR75","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11910-018-0898-3","volume":"18","author":"J Hammes","year":"2018","unstructured":"Hammes J, Drzezga A, van Eimeren T (2018) The role of tau imaging in parkinsonian disorders. Curr Neurol Neurosci Rep 18:86. https:\/\/doi.org\/10.1007\/s11910-018-0898-3","journal-title":"Curr Neurol Neurosci Rep"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05601-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05601-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05601-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T21:16:14Z","timestamp":1638566174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05601-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":75,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5601"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05601-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"20 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}